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Conclusions: This is the ﬁrst description of PA CL-resistance in Italian CF patients.
Although in very low percentage (2.2 %) this emergence needs concern in the
extensive and prolonged use of this important therapeutic option. Moreover, in the
CF microbiology workout, seems to be mandatory the CL (or polimixin B) routinely
testing in all PA isolates.
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Background: The initial source of PA acquisition remains unknown in most CF
patients (pts), but the environment is one of the possible sources. Water is the
natural habitat for PA, but at the moment, there are limited published data about
the prevalence of PA in swimming pools and the real risk of acquisition for CF pts.
Aim: Characterize PA recovered from swimming pools, in order to determine
genetically similarity with strains isolated from CF pts.
Methods: A collection of 30 strains from 7 swimming pools of Ligurian region,
isolated by the ARPAL Microbiology Laboratory, were characterized for antibiotic
resistance and hypermutable (HMP) phenotype by disk-diffusion and E-test (Macia
et al 2004). All strains were genotyped by Box-PCR (Rademarker J.L.W, et al
1998) and the genetically relatedness was assessed by Gel Compare II analysis. A
comparison with 240 previously genetically characterized strains isolated from 121
pts of Genova CF Centre was performed.
Results: All the strains were susceptible to Ciproﬂoxacin, Tobramycin and Colistin,
the antibiotic resistance (%) was: Meropenem 20, Gentamicin 7, Ceftazidim 3,
Piperacillin/Tazobactam 3, Ticarcillin/Clavulanate 3, Amikacin 3, Ticarcillin 3 and
Aztreonam 3. 1/30 (3%) strain showed a HMP phenotype. By Box-PCR a total of
16 genotypes were found: 11 genotypes were not shared, while 5 were shared. In
particular 5 clusters were found, with different size of swimming pools: 3 of 2 and 2
of 3. No genetic correlation was observed between swimming pools and CF strains.
Conclusions: This study shows that PA recovered from swimming pools have a
phenotype with low resistance to antimicrobial agents and a low occurrence of HMP
strains. Our results show that a large number of different PA genotypes are present
in swimming pools of Ligurian region. Although our data did not demonstrate any
PA genotype shared by CF pts and swimming pools strains, care should be taken
anyway suggesting CF pts to attend any swimming pool.
*This Poster has been presented also as Oral Communication, by invitation of
the Scientiﬁc Committee
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Introduction: Achromobacter xylosoxidans (A. xylosoxidans) has been increasingly
recognized as a cause of respiratory tract colonization in Cystic Fibrosis (CF). The
pathogenic role of this Gram-negative bacteria is yet unclear. The present study
was conducted to investigate the epidemiology of A. xylosoxidans isolates recovered
from CF patients. Misidentiﬁcation of A. xylosoxidans can occur, therefore the pres-
ence of respiratory tract infections caused by this bacteria might be underestimated.
Epidemiology of A. xylosoxidans in CF is not well understood: it can cause
temporary or persistent infection in the respiratory tract. A total of 55 isolates
were detected persistently in 8 out of 260 CF patients over a prolonged period of
time (from 2 to 8 years).
Aims: Sequential A. xylosoxidans strains of 8 CF patients were genotyped in order
to detect if these patients are persistently colonized, or whether a cycle of acquisition
and clearing has occurred.
Methods: Lactose-negative on McConkey agar and oxidase-positive colonies were
ﬁrstly identiﬁed using API20NE (bioMerieux), then conﬁrmed by PCR. This
molecular method allows to identify A. xylosoxidans recovered from CF patients
sputum with a sensivity of 100% and speciﬁcity of 97%, in order to distinguish
A. xylosoxidans isolates from several related glucose non-fermenting species.
Bacterial isolates were ﬁngerprinted by RAPD-PCR.
Results: Three out of 55 (5.5%) isolates were uncorrectly identiﬁed as A. xylosox-
idans and were not included in the epidemiological study. Isolates collected from 5
out of 8 patients exibited identical RAPD proﬁles, indicating that the same strain
persisted in the lungs of these patients. The remaining three patients are alternatively
colonized by few (2 or 3) different genotypes.
Conclusions: In an attempt to detemine whether CF patients acquired a single
isolate that they kept for years, or were periodically recolonized, serial isolates on a
subpopulation of 8 patients were examined. It appears that the majority of patients
(62.5%) have unique isolates, and only few patients are colonized by more than
one genotypes. A better understanding of the epidemiology of A. xylosoxidans may
help us to clarify the pathogenic potential of this unusual Gram-negative bacteria
in CF lung disease.
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Introduction: Pseudomonas aeruginosa is the most important opportunistic
pathogen in Cystic Fibrosis (CF) patients. The presence in P. aeruginosa of acquired
metallo-b-lactamase (MBL), that confers broad-spectrum resistance to b-Lactam
antibiotics, represents an alarming phenomenon in clinical practice. Acquired
resistance determinants in patients with CF are not commonly found and blaIMP
genes have never been described. In this study we report about the ﬁrst identiﬁcation
of an IMP-type MBL in isolates of P. aeruginosa from a CF patient.
Methods: Isolates of P. aeruginosa with a proﬁle suggesting the production of MBL
collected from eight patients attending the Ospedale Bambin Gesu` in Rome have
been analysed. Hybridization, PCR and DNA sequencing have been used to detect
blaIMP genes. Retrospective isolates have been included in the study. Clonality of
strains producing MBL have been analysed by genotyping work (RAPD/PFGE).
Results: From one out of eight patients (an 8-year-old girl), a P. aeruginosa strain
producing an IMP-type resistance determinant, encoded by the gene variant blaIMP
has been isolated. The analysis of the retrospective isolates from the patient, as
well as their clonality, demonstrated the persistence of the isolate producing IMP-
13 along a period of 3 years. Besides, the analysis has highlighted the presence
of this resistance determinant since the ﬁrst time the patient has been colonized
by P. aeruginosa. The clinical course of the patient has been characterised by
pulmonary exacerbations, with a slow but progressive decline of pulmonary function
(FEV1: 88%) despite repeated antibiotic cycles (aminoglycosides and quinolonics).
Conclusions: Metallo-b-lactamase (MBL) blaIMP, widespread in Italy, has been
isolated for the ﬁrst time in P. aeruginosa strains from a patient with CF. This is an
alarming phenomenon which can have important implications for the therapeutic
as well as the surveillance ﬁeld.
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Background: We would like to introduce the clinical case of “Angela”, an Albanian
girl aged 24 months, who has been diagnosed by neonatal screening at our CF
Centre (Meyer Hospital, Florence, Italy).
Following and taking care of A. and her family represents and has represented since
CF diagnosis moment a very difﬁcult engagement because of the many unsuccessful
attempts of creation of a good collaborative relationship with A.’s parents. Our
difﬁculty is mainly correlated to the mother’s parental and attachment style that has
not permitted to understand for certain how she takes care of A. and manages her
daughter’s illness.
We hypothesize that the mother needs to consider the symptoms of her child as CF
related even if there is no clinical evidence. This hypothesis originated from the
different communications that the mother usually gives to the various operators of
the CF Centre about what happens to A. and how she faces the different illness
aspects and moments; doing that she shows an ambivalent relational style: frequent
treatment requests accompanying the difﬁculty or incapacity to follow the medical
indications, for instance she requested invasive medical checks for A. because of
abdominal-ache and at the same time she gave A. coke or other drinks with gas;
she did not confess that frankly but she minimized what happened when we asked
information about that. Moreover we have the perception of high risk for A.’s
physical and psychological health: she keeps facing many hospitalizations because
of ruinous situations of frequent vomiting and loss of weight that turn out well with
adequate therapy and controlled diet in a few days in hospital.
Clinical situation and clinical course: pancreatic insufﬁciency; frequently hospi-
talization for vomit, food refuse and very important weight loss; pulmonary disease
without main infection exacerbations, not Pseudomona aeruginosa colonisation.
During last hospitalization, for recurrent vomit and weight loss, we tried to perform:
– Esophageal pH 24 hours monitoring: not concluded because A. take off the tube;
– Gastrointestinal contrast radiographic study on narcotic state;
– Endoscopy, and ultrasound only showed a medium gastroesophageal reﬂux;
– Physiotherapy programme; feeding programme; pancreatic and antiacid therapy,
family psychological support.
Discussion: We ask ourselves how and how much it is necessary to protect A. from
her mother’s nurturing style by more important interventions to control the mother’s
psychological capacity about her role in the relationship with her daughter and in
the management of the illness.
